David Kennard, MBA, PhD, MRPHARMS

Senior Advisor, Business Development Therapeutics


Novateur Advisor Since



Business Development


Licensing and M&A, Devices, Immunology, Oncology & Immuno-Oncology, Therapeutics, COVID-19

"We develop a narrative and design a business development plan that faithfully translates technical Research & Development into differentiated benefits for patients, investors and society."

David Kennard, MBA, PhD, MRPHARMS
Senior Advisor, Business Development Therapeutics

Dr. David Kennard has over three decades in the pharmaceutical industry. His Business Development experience spans both the buy and sell side, and is under-pinned by a comprehensive understanding of research, development, and commercial requirements in developed and emerging markets, including regulatory and clinical development of small molecules, biologicals, devices, and diagnostics. Dr. Kennard is currently an industry advisor for the Follicular Lymphoma Foundation, and was most recently an advisor for restructuring and implementing change within the Commercial Partnerships Division, as well as leading the Opportunity Sourcing and Translation group within Cancer Research UK. His prior experience also includes Senior Advisor, Corporate Development at Gilead Sciences, where he lead the search and evaluation of product opportunities and candidate selection for Gilead’s core therapeutic areas of HIV/HBV, oncology, cardiopulmonary, and liver disease. Throughout his career, Dr. Kennard has led or participated in over 17 successful transactions.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!